Technology Brief -- ICN Pharmaceuticals Inc.:
   Russian Republic Approves
   Marketing of Virazole Drug
Virazole will be sold in Russia by the company's Eastern
European affiliate, ICN Galenika. Although not valid for the
entire Commonwealth of Independent States, the approval
brings to 21 the number of countries, including the U.S., in
which aerosolized Virasole is authorized for treatment of
infants with severe lower respiratory tract infection caused
by respiratory syncytial virus.